MENU

Articles for Vectura Group (LSE: VEC)

There could be hidden value in these FTSE 250 stocks

G A Chester discusses his two top-value picks from the FTSE 250 (INDEXFTSE:MCX). More »

These growth stocks are trading at major discounts

Are these two companies cheap enough to merit purchase right now? More »

Top stocks for June

We asked our analysts to share their top stock picks for the coming month. More »

Are these bombed-out pharma stocks worth buying?

Should you catch these falling knives? More »

2 FTSE 250 bargains I’d buy before it’s too late

These FTSE 250 (INDEXFTSE:MCX) stocks look set for strong growth. More »

Forget short-term pain: 2 growth stocks for long-term gain!

Royston Wild discusses two growth lovelies for long-term investors. More »

Why this growth stock could double by 2019

Bilaal Mohamed reckons this pharmaceutical stock could double within the next couple of years. More »

2 shares with explosive long-term growth potential

These stocks have the potential to produce growth for years to come. More »

3 growth stocks I’d buy right now

The next few years could see rich pickings among growth shares. More »

Top stocks for February

We asked our analysts to share their top stock picks for the coming month. More »

One growth stock I’d buy and one I’d sell in February

G A Chester reveals one mid-cap he'd buy and one he'd sell. More »

Why I see 50% upside in this pharmaceutical firm in 2017

Bilaal Mohamed explains why this pharamceutical firm could have massive growth potential over the coming year. More »

Will Vectura Group plc outperform AstraZeneca plc after today’s results gain a Brexit boost?

Is Vectura Group plc (LON: VEC) a more attractive buy than healthcare peer AstraZeneca plc (LON: AZN)? More »

Could Vectura Group plc grow to be a FTSE 100 company within 10 years?

Vectura Group plc (LON:VEC) could follow in the footsteps of Hikma Pharmaceuticals (LON:HIK), says G A Chester. More »

2 pharmaceutical shares that could make you a fortune

Bilaal Mohamed uncovers two pharmaceutical firms with the potential to deliver substantial shareholder returns. More »

Why Vectura group plc and GlaxoSmithKline plc could be the perfect combination

GlaxoSmithKline plc (LON: GSK) and Vectura Group plc (LON: VEC) have many complementary qualities. More »

Should You Ditch GlaxoSmithKline plc And Buy Vectura Group PLC And SkyePharma PLC?

Are these 2 pharmaceutical stocks better buys that GlaxoSmithKline plc (LON: GSK)? Check out Vectura Group PLC (LON: VEC) and SkyePharma PLC (LON: SKP). More »

Are Vectura Group PLC, AstraZeneca plc And Lookers PLC ‘Screaming Buys’?

Should you add these 3 stocks to your portfolio? Vectura Group PLC (LON: VEC), AstraZeneca plc (LON: AZN) and Lookers PLC (LON: LOOK) More »

Are Vectura Group PLC And Circassia Pharmaceuticals PLC Better Buys Than GlaxoSmithKline plc?

Should you add Vectura Group PLC (LON: VEC) and Circassia Pharmaceuticals PLC (LON: CIR) to your portfolio before GlaxoSmithKline plc (LON: GSK)? More »

Why Vectura Group PLC Could Be The Perfect Partner For AstraZeneca plc In Your Portfolio

These 2 pharmaceutical companies look set to soar: Vectura Group PLC (LON: VEC) and AstraZeneca plc (LON: AZN) More »